-
Six Georgians tried in France over theft of rare Russian books
-
US trade gap narrows in April on oil exports boost
-
Stocks rise, oil eases after Trump evokes Iran deal
-
Townsend says Dempsey still part of Scotland set-up despite Japan move
-
Trump-linked resort plan ignites Albanian discontent
-
Itoje out of latest England training squad
-
Acid attack on woman doctor sparks fear, protests in Pakistan
-
McKeown battles illness to surge home in 100m backstroke at Australian trials
-
Europe's top firms fuelling inequality with payouts: Oxfam
-
UK government 'concerned' by abuse claims against West Ham co-owner
-
What we know about Xi's visit to North Korea
-
Japan city relieved as bear caught after roaming streets for days
-
Kenyan police fire tear gas, make arrests at US Ebola centre protest
-
Mosaddek steers Bangladesh to 284-8 against sloppy Australia
-
Jota will be in Scotland skipper Robertson's 'heart' at World Cup, says widow
-
Outdoor hospitals, shaken communities as Philippine quake toll hits 41
-
German factory output, exports rise but Iran war weighs
-
Left-winger beats Republican to advance to LA mayor runoff: media
-
Pakistan, Lebanon army chiefs meet as Middle East mediation drags on
-
Between Homer and Hollywood: Troy a source of Turkish pride
-
Success-starved China fans adopt 'Card Master' referee as World Cup rep
-
Seven Georgians tried in France over theft of rare Russian books
-
Trump says in 'final throes' of reaching Middle East peace deal
-
Business, unions unite against Swiss immigration cap push
-
Outdoor hospitals, cut-off communities as Philippine quake toll hits 41
-
Spain beat Peru 3-1 to head into World Cup on high
-
China exports surge as Beijing withstands Middle East stress
-
Spurs edge Knicks 115-111 in NBA Finals as Trump booed
-
Hopes soar for US fans as hosts assemble at World Cup camp
-
French justice minister refuses to resign over girl killing case
-
Asian stocks track Wall St tech bounce, oil eases on Mideast hope
-
Encouraging trial results for AstraZeneca's new weight-loss pill
-
Hundreds evacuated as waves batter New Zealand capital
-
Former rugby league star in Australia comes out as gay
-
Bolivian president says 'narcoterrorists' behind crippling protests
-
World Cup nears kickoff after pre-tournament turbulence
-
Trump gets cold hometown welcome at NBA Finals in New York
-
Deschamps tips hat-trick man Olise to make big impact at World Cup
-
Australia Social Media Ban: Majority of Australian Parents and Children Report Positive Outcomes for Children’s Mental Health, Yet Half Keep At Least Some Of Their Accounts, FOSI Research Finds
-
Great Western Mining Corporation PLC Announces Holding(s) in Company - 2
-
SPORT BEACH Launches Women's Leadership Council, Fueled by Gatorade
-
Mobile Kitchen Solutions Strengthens National Growth Strategy with Addition of Jeff Vigilante
-
7 Days Left: LiberNovo Maxis, Big & Tall's Ultimate Seat
-
Maison Solutions Inc. Announces Strategic Collaboration with SupplyAi and MiniMax to Explore AI-Native Food Supply Chain Solutions
-
FossID Announces Workflows to Help Enterprises Operationalize SBOM Lifecycle Management Across Complex Software Supply Chains
-
Fast Moving Consumer Goods, Inc. (GGII) Launches Weekly Webinar for Investors and Consumer Goods Professionals Amid Rapid Transformation in the FMCG Industry
-
Lexaria's Animal Study Examining Next-Generation GLP-1 drugs is Underway
-
Rain Enhancement Technologies Reports WETA Delivers New Water at $10 Per Acre-Foot, a Fraction of the Cost of Conventional Supply Alternatives
-
TurboTenant Partners with Snappt to Bring Industry-Leading Fraud Detection and Income Verification to Independent Landlords
-
Worksport Ltd. Reports Additional $50,000 CEO Insider Stock Acquisition, Reinforcing Confidence in Long-Term Value Creation
Nitches, Inc. (OTC:NICH) Prepares Thursday Soft Launch of a Platform That Lets Anyone Build a Supplement Brand From Idea to Shelf, and See How It Scores Before They Spend a Dollar
The company that had to survive its own scrutiny is opening the door it once had to build alone, with FDA-registered manufacturing partners standing behind every formula.
MIAMI, FL / ACCESS Newswire / June 9, 2026 / Nitches, Inc. (OTC:NICH) today confirmed that it will soft launch a new consumer-facing platform this Thursday, built on a simple idea the supplement industry has never made simple: you should be able to take an idea for a product and turn it into a real, manufactured, shelf-ready brand without needing a lab, a lawyer, and a decade of relationships first.
Most people with a supplement idea never make it. Not because the idea was wrong. Because the path was closed. Sourcing, formulation, compliance, manufacturing, and distribution were five different doors, each one locked, each one expensive, each one requiring a relationship the newcomer did not have. Nitches knows that path because the company walked it the hard way. The new platform is the door Nitches wishes had existed when it started.
Here is what changes on Thursday. An aspiring founder will be able to take an idea, say, an ashwagandha-based formula for rest and recovery, and build it on the platform. They will see, in real time, how that formula scores against live federal enforcement and evidence data before they commit a single dollar. They will see which claims appear more consistent with existing enforcement guidance and which may present greater regulatory risk. And if they want to go further, they will be able to align with Nitches and its FDA-registered manufacturing partners to take that idea from concept to scale.
"The market does not have a transparency problem because people lack ideas," a company spokesperson said. "It has a transparency problem because nobody could see whether their idea would survive before they bet everything on it. We built the thing that lets you see first. Then we built the bridge to actually make it."
The strategic logic is consistent with the thesis Nitches set out earlier this year. Most supplement companies do not fail because their product is wrong. They fail because scrutiny, regulatory, financial, or operational, arrived after the capital was already committed. Nitches is positioning itself as the layer that surfaces that scrutiny first, and then connects the founder to the manufacturing relationships that turn a validated concept into a finished product. The company's experience operating in the market informed the platform's development.
What the platform is designed to make possible for aspiring founders:
Build a concept online and watch it scored in real time, before spending on inventory.
See which ingredients and claims appear more consistent with existing enforcement guidance, and which may present greater regulatory risk.
Align with Nitches and its FDA-registered manufacturing partners to move from idea to manufactured product.
Carry a documented record forward, the kind of record retail buyers and distributors increasingly ask to see.
The full reveal, including how to build your own concept and see your own score, will begin Thursday. Nitches is asking those who are curious, and especially those who have always wanted to develop their own brand, to follow the company on social media for the first look. For anyone who has ever thought "I could make a better version of that," this is the week to be watching.
Nitches expects this soft launch to be the first in a sequence of announcements as the platform opens to outside founders.
About Nitches, Inc.
Nitches, Inc. (OTC:NICH) is a publicly traded company refocused on supplements and lifestyle enhancement, built on a manufacturing and intelligence platform designed to carry founders from concept to distribution under a defined product integrity standard. The company's objective is to make the path it once had to walk alone available to the next generation of aspiring supplement founders.
Forward-Looking Statements
Certain statements in this press release constitute "forward-looking statements" within the meaning of federal securities laws. These statements are based on current expectations, estimates, and projections regarding the business of Nitches, Inc., and speak only as of the date hereof. Words such as "will," "expects," "designed to," "positioning," "plans," and similar expressions identify forward-looking statements. Actual results or developments may differ materially from those projected, and there is no assurance that the platform, its features, its manufacturing relationships, or its launch timing will perform or proceed as described. Nitches undertakes no obligation to update any forward-looking statement except as required by law.
These products and statements have not been evaluated by the Food and Drug Administration (FDA). They are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary. Always consult a healthcare professional before beginning any supplementation program. Platform output is informational and does not constitute legal or regulatory advice. Founders remain responsible for their own regulatory compliance.
IR Contact:
John Morgan
CEO, Nitches, Inc.
[email protected]
SOURCE: Nitches, Inc.
View the original press release on ACCESS Newswire
P.Martin--AMWN